Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities:    
Net loss $ (27,442) $ (10,488)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 119 61
Intangible asset impairment charges   500
Amortization of debt discounts and issuance costs 3,740  
Costs of warrants issued at IPO 5,790  
Write-off of debt discounts and issuance costs at IPO 10,132  
Change in fair value of warrant liability (7,114)  
Provision for doubtful accounts 67  
Stock-based compensation expense 1,903 1,522
Changes in assets and liabilities:    
Accounts receivable (7,476) (379)
Expenditures billable to clients (4,918) (2,818)
Prepaid expenses and other current assets (1,303) (284)
Accounts payable 6,042 (4,810)
Accrued media payments 2,206 1,051
Other accrued liabilities 529 127
Customer advances 1,248 (94)
Net cash used in operating activities (16,477) (15,612)
Cash flows from investing activities:    
Addition to intangible assets (30)  
Net cash used in investing activities (30)  
Cash flows from financing activities:    
Net proceeds from public offering 33,199  
Proceeds received under the Bridge Loan Agreement 8,000  
Proceeds from exercise of Primary Warrant 29,263  
Proceeds from exercise of stock options 3  
Debt issuance costs (68)  
Repurchase of common stock (56)  
Net cash provided by financing activities 70,341  
Net increase (decrease) in cash and cash equivalents 53,834 (15,612)
Cash and cash equivalents, beginning of period 12,078 19,197
Cash and cash equivalents, end of period 65,912 $ 3,585
Non-cash investing and financing activities:    
Conversion of convertible notes payable, including accrued interest, to common stock 28,782  
Conversion of redeemable convertible preferred stock to common stock 27,266  
Unpaid deferred IPO costs $ 665